ScoutQuest6 Oct 2026
Shukra Pharmaceuticals524632Stock price alert

Clarification on recent price movement: no undisclosed price-sensitive information

Company replies to BSE's email seeking a clarification on recent price movement.

What happened

BSE sought a clarification from Shukra Pharmaceuticals Ltd on a significant movement in the price of the company's security at the Exchange in the recent past. The company's Company Secretary and Compliance Officer has replied to that email.

What the company said

How to read this

Exchanges ask listed companies for such clarifications when a scrip moves sharply, to check whether any information is pending disclosure. The reply here is the company's own statement of its position: it says nothing undisclosed is pending and that the movement reflects natural market forces rather than any company action.

What it means for an investor

Source: BSE · 6 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.